Pricing Log in Create free account

CalciMedica Inc. (CALC) vs IN8bio, Inc. (INAB)

CalciMedica Inc. and IN8bio, Inc. are both Biotechnology companies. CalciMedica Inc. and IN8bio, Inc. are of similar size ($8.9M and $8.2M). Across the 11 metrics below, IN8bio, Inc. leads on 8 and CalciMedica Inc. on 3.

Valuation

Metric CALC INAB Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 0.79 0.89 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.13 0.08 0.65
EV/Sales n/m n/m 8.98
Earnings yield (527.34%) (255.95%) (34.89%)
Free cash flow yield (435.92%) (89.47%) (24.52%)

Profitability

Metric CALC INAB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (365.70%) (111.11%) (50.12%)
Return on assets (110.10%) (90.80%) (45.60%)
Return on invested capital 0.00% (2,948.56%) 0.00%

Growth

Metric CALC INAB Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (61.48%) 74.06% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CALC INAB Biotechnology median
Debt to equity 1.67 0.00 0.00
Current ratio 5.58 8.21 4.89
Net debt to EBITDA 0.14 1.56 1.01

Dividend

Metric CALC INAB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CALC INAB Biotechnology median
Market cap 8.87m 8.19m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack